BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Velikyan I. (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer. Pharmaceuticals (Basel) 2020;13:E39. [PMID: 32151049 DOI: 10.3390/ph13030039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Corlett A, Sani MA, Van Zuylekom J, Ang CS, von Guggenberg E, Cullinane C, Blyth B, Hicks RJ, Roselt PD, Thompson PE, Hutton CA, Haskali MB. A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin-2 Receptor-Positive Cancer. J Med Chem 2021;64:4841-56. [PMID: 33826325 DOI: 10.1021/acs.jmedchem.0c02213] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lescure R, Privat M, Pliquett J, Massot A, Baffroy O, Busser B, Bellaye PS, Collin B, Denat F, Bettaïeb A, Sancey L, Paul C, Goze C, Bodio E. Near-infrared emitting fluorescent homobimetallic gold(I) complexes displaying promising in vitro and in vivo therapeutic properties. Eur J Med Chem 2021;220:113483. [PMID: 33915372 DOI: 10.1016/j.ejmech.2021.113483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shende P, Gandhi S. Current strategies of radiopharmaceuticals in theranostic applications. Journal of Drug Delivery Science and Technology 2021;64:102594. [DOI: 10.1016/j.jddst.2021.102594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]